Mayo Clinic - One in 20 people will be diagnosed with colorectal cancer in their lifetime. If detected early, colorectal cancer has a 90% survival rate. Learn more about screening and prevention:
![The surgical specimens of the ascending colon cancer (a), descending... | Download Scientific Diagram The surgical specimens of the ascending colon cancer (a), descending... | Download Scientific Diagram](https://www.researchgate.net/publication/344075403/figure/fig4/AS:932568761368578@1599353127199/The-surgical-specimens-of-the-ascending-colon-cancer-a-descending-colon-cancer-b-and.jpg)
The surgical specimens of the ascending colon cancer (a), descending... | Download Scientific Diagram
![Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report | Surgical Case Reports | Full Text Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report | Surgical Case Reports | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40792-020-00963-1/MediaObjects/40792_2020_963_Fig1_HTML.png)
Undifferentiated carcinoma of the transverse colon with rhabdoid features that developed during treatment of non-small cell lung carcinoma with pembrolizumab: a case report | Surgical Case Reports | Full Text
![Does it matter if colon cancer is on the left or right side? | Roswell Park Comprehensive Cancer Center - Buffalo, NY Does it matter if colon cancer is on the left or right side? | Roswell Park Comprehensive Cancer Center - Buffalo, NY](https://www.roswellpark.org/sites/default/files/styles/max_325x325/public/partsofcolon2.jpg?itok=dusIkS0t)
Does it matter if colon cancer is on the left or right side? | Roswell Park Comprehensive Cancer Center - Buffalo, NY
![Good response to leucovorin and fluorouracil plus oxaliplatin and cetuximab therapy in a patient with metastatic ascending colon cancer harboring a KRAS p.G13D mutation Good response to leucovorin and fluorouracil plus oxaliplatin and cetuximab therapy in a patient with metastatic ascending colon cancer harboring a KRAS p.G13D mutation](https://www.spandidos-publications.com/article_images/ol/3/2/OL-03-02-0269-g03.jpg)